Instrument Inactif

Communiqués Tricida, Inc.

Actions

TCDA

US89610F1012

Recherche biotechnologique et médicale

Communiqués

15/03/23	Tricida : Acquisition/Asset Disposal - Form 8-K	PU
25/02/23	TRICIDA, INC. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)	AQ
23/02/23	TRICIDA, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	AQ
17/02/23	TRICIDA, INC. : Other Events, Financial Statements and Exhibits (form 8-K)	AQ
27/01/23	TRICIDA, INC. : Financial Statements and Exhibits (form 8-K)	AQ
17/01/23	TRICIDA, INC. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits (form 8-K)	AQ
12/01/23	TRICIDA, INC. : Entry into a Material Definitive Agreement, Bankruptcy or Receivership, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)	AQ
04/01/23	Tricida : Accelaration/Increase of Financial Obligation - Form 8-K	PU
04/01/23	TRICIDA, INC. : Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Financial Statements and Exhibits (form 8-K)	AQ
22/12/22	TRICIDA, INC. : Other Events, Financial Statements and Exhibits (form 8-K)	AQ
12/12/22	Tricida : Termination of Material Agreement - Form 8-K	PU
12/12/22	TRICIDA, INC. : Termination of a Material Definitive Agreement, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits (form 8-K)	AQ
07/12/22	Tricida : Failure to Satisfy Listing Rule - Form 8-K	PU
07/12/22	TRICIDA, INC. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits (form 8-K)	AQ
17/11/22	TRICIDA, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	AQ
14/11/22	TRICIDA, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	AQ
14/11/22	Tricida Announces Third Quarter 2022 Financial Results	BU
02/11/22	TRICIDA, INC. : Other Events, Financial Statements and Exhibits (form 8-K)	AQ
02/11/22	Tricida Provides Strategic Update	BU
24/10/22	TRICIDA, INC. : Other Events, Financial Statements and Exhibits (form 8-K)	AQ
24/10/22	Tricida Reports Topline Results from the VALOR-CKD Phase 3 Trial of Veverimer	BU
20/10/22	TRICIDA, INC. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)	AQ
19/10/22	Tricida Announces $125 Million Debt Facility with Hercules Capital	BU
03/10/22	Tricida Announces the Selection of the VALOR-CKD Trial for an Oral Presentation in the High-Impact Clinical Trials Session at ASN Kidney Week 2022	BU
24/09/22	TRICIDA INVESTIGATION CONTINUED By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Tricida, Inc. - TCDA	BU